Literature DB >> 19284389

Molecular analysis: microsatellity instability and loss of heterozygosity of tumor suppressor gene in hereditary non-polyposis colorectal cancers (HNPCC).

Vesna Hadziavdić1, Nada Pavlović-Calić, Izet Eminović.   

Abstract

HNPCC (Hereditary non-polyposis colorectal cancers) development is caused by mutation of genes included in system of mismatch repair genes. The mutation exists at 60% of patients in hMSH2 gene, 30% in hMLH1 and 10% both in hPMS1and hPMS2 genes. RER+ exists in about 90% in hereditary non-polyposis colorectal cancer and about 15-28% in sporadic cancers. The purpose of the study was to determine highly sensitive microsatellite markers which can be fast and efficient way of microsatellite screening for detection of HNPCC patients. Moreover, we have analysed the loss of heterozygosity of tumour suppressor genes which could have the diagnostic value in detection of HPNCC patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284389      PMCID: PMC5645541          DOI: 10.17305/bjbms.2009.2850

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  35 in total

1.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

2.  Microsatellite instability as an indicator of hereditary susceptibility to colon cancer.

Authors:  P Peltomäki
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

Review 3.  Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.

Authors:  T Bocker; J Rüschoff; R Fishel
Journal:  Biochim Biophys Acta       Date:  1999-05-31

4.  Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.

Authors:  M P de Leon; M Pedroni; P Benatti; A Percesepe; C Di Gregorio; M Foroni; G Rossi; M Genuardi; G Neri; F Leonardi; A Viel; E Capozzi; M Boiocchi; L Roncucci
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  Approaches to identification of HNPCC suspected patients in Slovak population.

Authors:  I Fridrichová; D Ilencíková; W Friedl; P Hlavcák; M Skorvaga; P Krizan; J Pálaj; M Pirsel; E Farkasová; Z Bartosová
Journal:  Neoplasma       Date:  2000       Impact factor: 2.575

6.  Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.

Authors:  Kristina Lagerstedt Robinson; Tao Liu; Jana Vandrovcova; Britta Halvarsson; Mark Clendenning; Thierry Frebourg; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Päivi Peltomäki; Richard D Kolodner; Mef Nilbert; Annika Lindblom
Journal:  J Natl Cancer Inst       Date:  2007-02-21       Impact factor: 13.506

7.  Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.

Authors:  H Yamamoto; H Sawai; M Perucho
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

8.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.

Authors:  U Schiemann; Y Müller-Koch; M Gross; J Daum; P Lohse; G Baretton; M Muders; T Mussack; R Kopp; E Holinski-Feder
Journal:  Digestion       Date:  2004-04-28       Impact factor: 3.216

10.  Extensive molecular screening for hereditary non-polyposis colorectal cancer.

Authors:  B Dieumegard; S Grandjouan; J C Sabourin; M L Le Bihan; I Lefrère; J P Pignon; P Rougier; P Lasser; J Bénard; D Couturier; B Bressac-de Paillerets
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.